BackTable / VI / Topic / Procedure
Learn more on the BackTable VI Podcast
BackTable is a knowledge resource for physicians by physicians. Get practical advice on Y90 Radioembolization and how to build your practice by listening to the BackTable VI Podcast, reading exclusing BackTable Articles, and following the work of our Contributors.
Reflect on how this Podcast applies to your day-to-day and earn free AMA PRA Category 1 CMEs. Follow the button below to claim your credits on CMEfy.
Stay Up To Date
Y90 Radioembolization Podcasts
Listen to leading physicians discuss y90 radioembolization on the BackTable VI Podcast. Get tips, tricks, and expert guidance from your peers and level up your practice.
In this crossover episode between BackTable VI and BackTable Innovation, Dr. Chris Beck interviews Dr. Riad Salem (Chief of Interventional Radiology at Northwestern University) and Peter Pattison (President of Interventional Oncology at Boston Scientific) about how TheraSpheres for Y90 radioembolization became a mainstay in the IR toolkit for HCC and where the technology is heading next.
Transplant Surgeon Dr. Jennifer Berumen and Interventional Radiologist Dr. Isabel Newton discuss the treatment of HCC and the importance of multi-specialty collaboration in bridging these patients to successful liver transplantation. Special discussion was given around this HCC consortium article in Annals of Surgery: https://pubmed.ncbi.nlm.nih.gov/30870180/
Y90 Radioembolization Articles
Read our exclusive BackTable VI Articles for quick insights on y90 radioembolization, provided by physicians for physicians.
A pressure directed device may help increase control of Y90 radioembolization delivery to the tumor in hepatocellular carcinoma (HCC). Having performed around 200 pressure directed procedures, Dr. Nutting describes his use of Surefire’s guide catheter and microcatheters when working with the Surefire Infusion System.
When treating HCC with Y90 radioembolization, a hypovascular tumor with low visibility on angiogram can indicate that a pressure directed device may help to deliver more of the intended dose to the tumor. Studies have shown that pressure directed devices increase tumor uptake and decrease non-target embolization.
The goal of Y90 radioembolization is to deliver the full dose of therapeutic to the tumor. Pressure directed therapy intermittently stops arterial flow and pushes therapeutic into the tumor using pressure that builds up during infusion, overcoming some of the technical limitations of end-hole catheters.
Y90 Radioembolization Demos
Watch video walkthroughs of y90 radioembolization on the BackTable VI expanded content network.
Y90 Radioembolization Tools
Check out y90 radioembolization apps, calculators, and decision aids to assist you in your day to day practice.
Disclaimer: The Materials available on https://www.BackTable.com are for informational and educational purposes only and are not a substitute for the professional judgment of a healthcare professional in diagnosing and treating patients. The opinions expressed by participants of the BackTable Podcast belong solely to the participants, and do not necessarily reflect the views of BackTable.